WO2002082898A1 - Novel endophytic fungi and methods of use - Google Patents
Novel endophytic fungi and methods of use Download PDFInfo
- Publication number
- WO2002082898A1 WO2002082898A1 PCT/US2002/011769 US0211769W WO02082898A1 WO 2002082898 A1 WO2002082898 A1 WO 2002082898A1 US 0211769 W US0211769 W US 0211769W WO 02082898 A1 WO02082898 A1 WO 02082898A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- muscodor
- effective amount
- organism
- contacting
- albus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/30—Microbial fungi; Substances produced thereby or obtained therefrom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/30—Fuel from waste, e.g. synthetic alcohol or diesel
Definitions
- the present invention relates to the isolation of novel fungi that produce volatile antibiotics.
- the volatile compounds have biological activity against plant and human pathogenic fungi and bacteria, insects and nematodes.
- fungi produce antibiotics that are useful in the treatment of diseases, in industrial applications and as pesticides, e.g., penicillin, cephalosporins, tetracyclin, and cyclosporins, none of which are volatile.
- pesticides e.g., penicillin, cephalosporins, tetracyclin, and cyclosporins, none of which are volatile.
- Many fungal species are known to emit low concentrations of gaseous substances, especially ones that have distinctive obnoxious odors, and this has prompted chemical analyses of the fungal volatiles (Bjurman et al., 1992). Some of these volatile substances are common to many fungi, whereas others seem to be unique for one species (Schnurer et al., 1999; Rapior et al., 2000). Dennis & Webster (1971) reported that certain Trichoderma spp.
- Novel endophytic fungi including Muscodor albus and Muscodor roseus are provided that produce a mixture of volatile antibiotics with activity against fungi, bacteria, insects and nematodes.
- the Muscodor is identified using the information provided herein, including, but not limited to partial genomic sequences set forth in SEQ ID NOs.: 1 to 4. Two novel strains were deposited with the NRRL on February 1, 2002 under the provisions of the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purpose of Patent Procedure under Accession Nos. 30457 and 30458.
- compositions containing the fungi and/or the volatile compounds are also provided.
- the compositions are useful to treat soil and to protect plants, seed, grain, and fruit from pathogenic fungi and bacteria.
- the compositions also are useful to protect postharvest food against bacterial and fungal infections.
- the compositions are further useful for treating human or animal waste and for treating and/or preventing toxic mold infestations of buildings and building materials such as wood. Methods of treating and protecting soil, plants, seed, grain, waste products, building materials and postharvest food products against bacterial, insecticidal, nematicidal and fungal infections are further provided by this invention.
- Table 1 shows the effects of the volatile compounds of M. albus and an artificial mixture of M. albus compounds on a group of test microbes. After exposure to M. albus gases, the test microbe was evaluated for its viability after removal from the gases.
- the artificial atmosphere consisted of the compounds identified after analysis of the M. albus gases.
- the microbial growth in the artificial atmosphere was measured after exposure to the artificial mixture of compounds at 3.2- 90 ⁇ l/50cc in order to obtain IC 50 's.
- the % growth over the control and viability were measured after exposure to 60 ⁇ l/50cc. Viability was determined after the removal of the compounds at 3 days.
- Table 2 shows the average number of broccoli seedlings per pot one week after planting (means ⁇ standard deviation) using vermiculite. Pots were planted immediately without an incubation period.
- Table 3 shows the results of an experiment determining the ability of Muscodor albus to control blue mold of apple.
- Table 4 shows the results of GC/MS analysis of the volatile compounds produced by M. albus. Several minor peaks and the breakthrough peak were omitted from the total analysis since they represent only 1% of the total area. Compounds found in the control PDA plate are not included in this table.
- Table 5 shows the results of an assay to determine the inhibitory influence of each class of volatile compounds. This is expressed as the % of the test microbe growth as compared to a control not in the presence of the test compounds.
- the compounds were tested for a 2 day exposure at the relative concentrations that they occur in M. albus at the optimum test concentration 60 ⁇ l/50 CC air space or 1.2 ⁇ l /cc.
- Table 6 shows Muscodor albus volatiles used to treat covered smut infested barley seeds. Sets of untreated and uninfested seeds were used as controls. MODES FOR CARRYING OUT THE INVENTION
- a cell includes a plurality of cells, including mixtures thereof.
- Known mechanisms of biological control include enteric bacteria that control root rot by out-competing fungi for space on the surface of the root.
- Bacterial toxins such as antibiotics, have been used to control pathogens.
- the toxin can be isolated and applied directly to the plant or the bacterial species may be administered so it produces the toxin in situ.
- fungus or "fungi” includes a wide variety of nucleated spore-bearing organisms that are devoid of chlorophyll. Examples of fungi include yeasts, molds, mildews, rusts, and mushrooms.
- bacteria includes any prokaryotic organism that does not have a distinct nucleus.
- Pesticidal means the ability of a substance to increase mortality or inhibit the growth rate of plant pests.
- Fungicidal means the ability of a substance to increase mortality or inhibit the growth rate of fungi .
- Insecticidal means the ability of a substance to increase mortality or inhibit the growth rate of insects or their larvae.
- Bactericidal means the ability of a substance to increase mortality or inhibit the growth rate of bacteria.
- Negidal means the ability of a substance to increase mortality or inhibit the growth rate of nematodes.
- Antibiotic includes any substance that is able to kill or inhibit a microorganism. Antibiotics may be produced by a microorganism or by a synthetic process or semisynthetic process. The term, therefore, includes a substance that inhibits or kills fungi for example, cycloheximide or nystatin.
- the term “culturing” refers to the propagation of organisms on or in media of various kinds.
- Whole broth culture refers to a liquid culture containing both cells and media.
- Supernatant refers to the liquid broth remaining when cells grown in broth are removed by centrifugation, filtration, sedimentation, or other means well known in the art.
- An “effective amount” is an amount sufficient to effect beneficial or desired results.
- An effective amount can be administered in one or more administrations. In terms of treatment and protection, an “effective amount” is that amount sufficient to ameliorate, stabilize, reverse, slow or delay progression of the target infection or disease states.
- “Positive control” means a compound known to have pesticidal activity.
- “Positive controls” include, but are not limited to commercially available chemical pesticides.
- the term “negative control” means a compound not known to have pesticidal activity. Examples of negative controls are water or ethyl acetate.
- the term “metabolite” or “volatile” refers to any compound, substance or byproduct of a fermentation of a microorganism that has the biological activity. Volatiles in most instances evaporate readily at ambient temperature and pressure.
- mutant refers to a variant of the parental strain as well as methods for obtaining a mutant or variant in which the desired biological activity is similar to that expressed by the parental strain.
- the "parent strain” is defined herein as the original Muscodor strains before mutagenesis. Mutants occur in nature without the intervention of man. They also are obtainable by treatment with or by a variety of methods and compositions known to those of skill in the art. For example, parental strains may be treated with a chemical such as N-methyl-N'-nitro-N-nitrosoguanidine, ethylmethanesulfone, or by irradiation using gamma, x-ray, or UV-irradiation, or by other means well known to those practiced in the art.
- composition is intended to mean a combination of active agent and another compound, carrier or composition, inert (for example, a detectable agent or label or liquid carrier) or active, such as an adjuvant.
- inert for example, a detectable agent or label or liquid carrier
- active such as an adjuvant
- examples of agricultural carriers are provided below.
- the fungi can also be formulated as a composition, with a carrier or alternatively, with at least one chemical or biological pesticide.
- Suitable formulations will be known to those skilled in the art (wettable powders, granules and the like, or can be microencapsulated in a suitable medium and the like, liquids such as aqueous flowables and aqueous suspensions, volatile compositions and emulsifiable concentrates. Other suitable formulations will be known to those skilled in the art.
- a “variant” is a strain having all the identifying characteristics of the strains of this invention and can be identified as having a genome that hybridizes under conditions of high stringency to the genome of the organism, the partial sequence of which has been deposited in the GenBank depository.
- “Hybridization” refers to a reaction in which one or more polynucleotides react to form a complex that is stabilized via hydrogen bonding between the bases of the nucleotide residues. The hydrogen bonding may occur by Watson-Crick base pairing, Hoogstein binding, or in any other sequence-specific manner.
- the complex may comprise two strands forming a duplex structure, three or more strands forming a multi-stranded complex, a single self-hybridizing strand, or any combination of these.
- Hybridization reactions can be performed under conditions of different "stringency.” In general, a low stringency hybridization reaction is carried out at about 40°C in 10 X SSC or a solution of equivalent ionic strength/temperature. A moderate stringency hybridization is typically performed at about 50°C in 6 X SSC, and a high stringency hybridization reaction is generally performed at about 60°C in 1 X SSC.
- a variant may also be defined as a strain having a genomic sequence that is greater than 85%, more preferably greater than 90% or more preferably greater than 95% sequence identity to the genome of M. roseus or M. albus.
- a polynucleotide or polynucleotide region (or a polypeptide or polypeptide region) has a certain percentage (for example, 80%, 85%, 90%, or 95%) of "sequence identity" to another sequence means that, when aligned, that percentage of bases (or amino acids) are the same in comparing the two sequences.
- This alignment and the percent homology or sequence identity can be determined using software programs known in the art, for example, those described in CURRENT PROTOCOLS IN MOLECULAR BIOLOGY (F.M.
- BLAST BLAST
- Muscodor a novel fungi named Muscodor.
- Two species of the novel Muscodor have also been isolated and characterized, i.e., Muscodor albus and Muscodor roseus.
- Partial genomic sequences for Muscodor albus are provided in SEQ ID NOS.: 1 and 2 and partial genomic sequences for Muscodor roseus
- gaseous composition(s) produced by the isolated Muscodor cultures.
- the volatile composition has the components recited in Table 4.
- the gaseous compositions can be combined with a suitable dispersing agent or carrier.
- the compositions optionally contain an effective amount of one or more of a fungicide, an insecticide, a nematicide, an antimicrobial, a bactericide or a food preservative.
- the fungi and the gases produced by the fungi are useful to inhibit the growth of or kill an organism selected from the group consisting of a fungus, a bacteria, a microorganism, a nematode and an insect.
- the fungi or its volatile byproduct is contacted with the organism in an amount effective to kill or inhibit the growth of the organism.
- the fungi and/or its volatile byproduct can be used to treat human or animal waste, e.g., as a component of a waste water or solid management or treatment. They also are useful to decontaminate human and animal waste, e.g., decrease or remove bacterial and fungal contamination.
- the fungi and/or its volatile byproduct can be used to treat or prevent toxic mold on building materials and in buildings by contacting the building, the building materials, or the spaces between the building materials with an effective amount of the volatile byproduct.
- an effective amount of the volatile byproduct can be used alone or in combination with other fumigants in a room or alternatively, during whole building fumigations.
- the invention provides a method for treating or protecting fruit, seeds, plants or the soil surrounding the plants from an infestation by an organism selected from the group consisting of a fungus, a bacteria, a microorganism, and an insect, by contacting the microorganism with an effective amount of an isolated Muscodor culture or its volatile byproduct.
- this invention is a method for identifying novel Muscodor fungi, comprising contacting an effective amount of the fungi to be screened with the volatiles of Muscodor albus or Muscodor roseus under culturing conditions and selecting the fungi which is resistant to the volatiles of the Muscodor albus or Muscodor roseus thereby identifying novel Muscodor fungi. Further provided are the isolated Muscodor fungi selected by this method.
- Fungus was isolated from several small limbs of a Fern-Leafed Grevellia (Grevillea pteridifolia) 12° 59' 39" South and 132° 28' 50" East obtained from the Northern Territory of Australia.
- Small pieces of inner bark, sapwood and outer xylem tissues of some small limbs were aseptically removed and placed on Petri plates containing water agar (Strobel et al., 1996). After incubation for several days, hyphal tips of developing fungi were aseptically removed and placed on potato dextrose agar (PDA).
- PDA potato dextrose agar
- TSBA Broth Agar
- CMA Corn Meal Agar
- MA Malt Agar
- PDA Potato Dextrose Agar
- Difco Laboratories, Detroit, Mich.
- TSBA Broth Agar
- CMA Corn Meal Agar
- MA Malt Agar
- PDA Potato Dextrose Agar
- Difco Laboratories, Detroit, Mich.
- fungus was inoculated on to Petri plates containing water agar with individual samples of small wood shavings of western white pine (Pinus monticola), black walnut (Juglans nigra), and maple (Acer saccharum) as well as bark pieces of C. zeylanicum in order to encourage spore production.
- the fungus was grown on sterilized Whatmann No. 1 filter paper discs that were placed on to the surface of PDA in Petri Plates. The fungus was inoculated as an agar plug in the middle of the filter paper disc on the PDA plate. The plate was incubated for 14 days at 22°C. The paper disc was then removed and placed in a laminar flow hood under sterile conditions for 1 day, or until the paper with its fungal mycelium was dry. The paper disc was then cut into many pieces and stored under various conditions. Also, agar plugs containing the fungus were placed in sterile distilled water and stored at 4°C.
- mycelial pieces growing on agar were placed in 15 % glycerol and stored at -70°C.
- fungal viability was determined by placing the mycelial fragments on to a PDA plate and examining it for fungal growth after 3-4 days.
- Muscodor roseus isolates designated internally as A3-5 and A- 10.
- the fungus was grown on sterilized Whatmann No. 1 filter paper discs that were placed on to the surface of PDA in Petri Plates.
- the fungus was inoculated as an agar plug in the middle of the filter paper disc on the PDA plate.
- the plate was incubated for 14 days at 22°C.
- the paper disc was then removed and placed in a laminar flow hood under sterile conditions for 1 day, or until the paper with its fungal mycelium was dry.
- the paper disc was then cut into many pieces and stored at 23°C, 4°C, 0°C and -70°C.
- agar plugs containing the fungus were placed in sterile distilled water and stored at 4°C.
- mycelial pieces growing on agar were placed in 15 % glycerol and stored at -70°C.
- fungal viability was determined by placing the mycelial fragments on to a PDA plate and examining it for fungal growth after 3-4 days.
- Example 4 Amplification of 18S Ribosomal DNA Partial nucleotide base pair fragments of the 18S r DNA gene from each fungus was amplified via the polymerase chain reaction (PCR) as a single fragment with the primer UK4F (5* CYGGTTGATCCTGCCRG) and UREV(5'GYTACCTTGACGA ACTT).
- PCR polymerase chain reaction
- PCR was performed in a 50 ⁇ l reaction vial containing 0.1 ⁇ g genomic DNA, 0.4 ⁇ M each primer, 0.16 mM four dNTPs and 5 ⁇ Taq polymerase (Promega) in a buffer of 10 mM tris-HCl (pH 9.0 at 25 ° C), 50 mM KCl, 3 mM MgCl 2> 0.1 % Triton X-100. Amplification was for 30 cycles (45 s at 94.5 ° C, 45 s at 53.5 ° C, 90 at 72.5 ° C).
- Example 5 Amplification of Internal Transcribed Space sequences (ITS) and 5.8S rDNA.
- the ITS regions of the test fungus was amplified using PCR and the universal
- ITS primers ITS5 (5' GGAAGTAAAAGTCGTAACAAGG) and ITS4 (5' TCCTCCGCTTATTGATATGC) (White et al., 1990).
- PCR was performed in a 50 ⁇ l reaction containing 0.1 ⁇ g genomic DNA, 0.4 ⁇ M each primer, 0.16 mM four dNTPs and 5u Taq polymerase (Promega) in a buffer of 10 mM tris-HCl (pH 9.0 at 25 ° C), 50 mM KCl, 3 mM MgCl 2 , and 0.1 % Triton X-100.
- PCR cycling conditions consisted of denaturation at 94 ° C for 1.5 min, annealing at 55 ° C for 2.5 min, and extension at 72 ° C for 3 min for 40 cycles, with a final extension at 72 ° C for 10 min (Willits, 1999).
- the PCR products were gel purified and desalted using the QuickStep PCR purification kit (Edge Biosystems).
- Both 18S rDNA and ITS1&2 sequences of culture collection "A3-5” were submitted to GenBank with serial number AY034664 and AY034665, respectively. While the 18S r DNA of isolate "A-10" was assigned AYO49023.
- both 18S rDNA and ITS1&2 sequences of "A3-5” also were searched or compared with other fungal sequences under BLAST 2.2.1 (Altschul et al., 1997), a search of NCBI at the web site http://www.ncbi.nlm.nih.gov/BLAST. Comparison and alignment sequences were done by using CLUSTALW version 1.7 (Thomson and Gibson, 1997), and manually aligned afterward.
- Muscodor albus AF324337
- Muscodor roseus AY034664
- Xylaria carpophila Z49785
- X. curta U32417)
- . hypoxylon U20378
- X. polymorpha AB014043
- a method was devised to analyze the gases in the air space above the M. albus mycelium growing in Petri plates.
- a "Solid Phase Micro Extraction" syringe was used to trap the fungal volatiles.
- the fiber material (Supelco) was 50/30 divinylbenzene/carburen on polydimethylsiloxane on a stable flex fiber.
- the syringe was placed through a small hole drilled in the side of the Petri plate and exposed to the vapor phase for 45 min. The syringe was then inserted into a gas chromatograph (Hewlett Packard 5890 Series II Plus) equipped with a mass-selective detector. A 30 m x 0.25 mm I.D.
- ZB Wax capillary column with a film thickness of 0.50 mm was used for the separation of the volatiles.
- the column was temperature programmed as follows: 25 °C for 2 min followed to 220 °C at 5°C/min.
- the carrier gas was Helium Ultra High Purity (local distributor) and the initial column head pressure was 50 kPa.
- the He pressure was ramped with the temperature ramp of the oven to maintain a constant carrier gas flow velocity during the course of the separation.
- the fiber Prior to trapping the volatiles, the fiber was conditioned at 240 °C for 20 minutes under a flow of helium gas. A 30 sec. injection time was used to introduce the sample fiber into the GC.
- the gas chromatograph was interfaced to a VG 70E-HF double focusing magnetic mass spectrometer operating at a mass resolution of 1500.
- the MS was scanned at a rate of 0.50 sec. per mass decade over a mass range of 35-360 amu.
- Data acquisition and data processing was performed on the VG SIOS/OPUS interface and software package. Initial identification of the unknowns produced by M. albus was made through library comparison using the NIST database.
- the quantitative analysis of each compound found in fungal cultures is based on its relative peak area obtained after GC-MS analysis. This number was used to prepare artificial atmospheres of the M. albus gases in the relative proportions that they occur in culture.
- esters that were not commercially available were made following some of the acylation procedures as set forth in Hoefle, G. et al., (1978).
- a strip of agar was removed from the middle of PDA plates, creating two approximately equal and separate sections where microorganisms could grow, as described by Strobel et al., 2001.
- One agar plug of M. albus culture was placed on one section and grown for 10 days with the plates enclosed in a plastic bag. After ten days, the other section was inoculated with various fungal pathogens, with sectioned plates without M. albus serving as control. There were three plates for each treatment. Penicillium expansum, Monilinia fructicola, Candida albicans and bacteria were applied as a spore/cell suspension, while the other pathogens were applied as a single 3 or 6 mm mycelial plug in each plate.
- Pathogen growth measured by colony diameter, was evaluated after 3 days. Reisolation of pathogens, to evaluate their viability, was attempted at the end of the experiments by lifting the agar in the inoculated area and transferring it to fresh PDA plates.
- the relative ability of the authenticated volatile M. albus compounds to inhibit and kill test organisms is also shown in Table 1. Test solutions were prepared by placing compounds in vials in the relative proportions that they occurred in the gas phase of M. albus cultures. The test mixture was placed in a presterilized microcup (4x6 mm) located in the center of a Petri plate containing PDA. When not in use, the mixture was stored at 0°C.
- test organisms freshly growing and excised on 3mm 3 agar blocks (at least 3 agar blocks per test fungus), were placed 2-3 cm from the microcup and the plate wrapped with two layers of parafilm. Measurements were made on mycelial growth from the edge of the agar blocks after a given time period. However, in the case of bacteria and Candida albicans they were streaked on the test side of the PDA plate and checked for new visible growth and viability by restreaking from the original area of the agar plate that had been inoculated. Appropriate controls were also set up in which no test solution was placed into the microcup.
- Tests on 3.2-90 ⁇ l of the artificial mixture per 50 CC of air space above the PDA plate were done on 3 replicates in order to obtain IC 50 data for each test organism.
- Individual classes of compounds were also tested in the relative amounts in which they occur at the optimum concentration of the entire mixture which is 60 ⁇ l of test mixture per 50 CC of air space above the culture in a standard Petri plate.
- the esters represent 44% of the mixture of the identified volatiles and were tested at 26.4 ⁇ l / 50 CC air space and the same procedure was used for each of the other classes of compounds that were identified.
- each individual compound, especially among the esters was tested at the concentration or relative percentage in which it occurs in 60 ⁇ l. Viability of the test microbes was made by aseptically removing the small agar block and placing it on a PDA plate and observing growth after 1-3 days.
- M. albus Based on the fact that the volatiles of M. albus can inhibit and kill E. coli (Table 1) experiments were done using M. albus to determine if its gases can inhibit and kill the microflora found in human and animal wastes such as E. coli and other fecal microbes. These microbes commonly are the cause of dysentery and other diseases during times of major crises including natural disasters, and wars. Conceivably, M. albus could be developed and used for field applications to decontaminate human and animal wastes. Thus, according to our experiments, a two week old colony of M. albus growing on a half side of a Petri plate containing PDA was prepared. Then on the separated other half plate was streaked (using standard microbiological methods) solid human waste.
- a control plate was set up in which no colony of M. albus was present. After two days, of incubation at 23°C, there were significantly more bacterial and fungal colonies growing in the control plate than the plate with M. albus. In a comparable experiment, M. albus was incubated solely in liquid human waste (urine) and total bacterial growth was precluded as contrasted to a control (without the M. albus) in which bacterial growth flourished.
- the growing medium is first infested with R. solani by adding one culture on a PDA plate to 1L of growing medium (vermiculite). This rate allows near 100 % seedling mortality with low variability among pots. Muscodor albus in various forms is then added to the growing medium, which is then placed in 3 inch plastic pots. The pots are planted with approximately 70 seeds of broccoli, placed in a tray and watered from the bottom. The seedlings are counted after approximately one week. Controls consist ofR. solani only, Muscodor albus only and plain growing medium. Depending on the experiment, there are 3 or 4 pots per treatment, arranged in a completely randomized design.
- a 10 day-old liquid culture of PDB was homogenized for a few seconds in a blender and incorporated at a rate of 50 or 200 ml per L of vermiculite.
- the solid agar culture treatment was done as described above, with 2 plates of 2 week-old culture per L. The pots were sown immediately after filling. The effect of sealing the volatiles in the pots was also investigated: for each treatment, a plastic bag was sealed over 3 pots with a rubber band while 3 other pots were left uncovered. The bags were removed after 3 days. Results show that liquid culture applied at the higher rate (200 ml L of vermiculite) was as effective in preventing damping off as solid Muscodor cultures on PDA (Table 2).
- Nematode (Caenorhabditis elegans)
- Paired microtitre plates were introduced into the boxes with armyworm larvae that had been grown for three days on artificial diet.
- the plate in the Muscodor box ceased feeding and remained stunted compared to the untreated controls. After five days, the armyworms in the treated plate were dead. Corn rootworm beetles, Diabrotica undecimpunctata
- Paired microtitre plates were introduced into the boxes with corn rootworm eggs that had been overlaid onto artificial diet. The eggs had just begun to hatch when the plates were introduced into the test boxes. Approximately half of the eggs hatched in the Muscodor box. The remainder did not hatch, and all of the neonates were dead within two days.
- the microtitre plate in the untreated control box developed a normal infestation that progressed with 3-6 third-instar grubs per well, after one-week.
- Example 14 Treatment of Smut Infested Barley Seeds with Muscodor albus
- 25 barley seeds infested with Ustilago hordei covered smut, Table 6
- Ustilago hordei covered smut, Table 6
- the plants were harvested and evaluated for smut in the seed heads.
- An identical number of control plants (untreated and U. hordei infested seed) had 50% and 41%, respectively of infected seed heads in this experiment. Also, as expected, uninfected seed yielded plants having no diseased grains.
- Muscodor albus gen. et sp. nov.
- the fungus is related to Xylariaceae by virtue of 96-98 % homology of its 18S rDNA (2089 bp) to representative members of this group.
- ITS1, 5.8S, and ITS2 sequences (652 bp) of M. albus showed close relatedness to several Xylaria spp. including X. arbuscula, X. longipes, an ⁇ X. m ⁇ li at the 89-92% level.
- Both the 18S rDNA and the ITS 1&2 5.8 S rDNA are unique, and therefore, Muscodor is considered a taxonomically distinct genus and species. (Worapong et al., 2001)
- the molecular characteristics of an organism are unique to it and it can be used to help in classification especially when critical structures (spore production) or other features are missing.
- the phylogenetic character mapping method combined with morphological data can assist in fungal identification.
- the rDNA genes are targeted for taxonomic purposes because they are highly conserved (Bruns et al., 1991; Guarro et al., 1999 and Mitchell et al., 1995).
- the ITS1&2 sequences are also conserved. After searching partial 18S rDNA sequences of M.
- M. roseus is a sister group to Muscodor albus (AF324337) with robust bootstrap confidence measured 100 % from 100 replications.
- maximum parsimony analysis shows that both M. albus and M. roseus are more closely related to the Xylariaceae e.g. Xylaria spp., Rosellinia necatrix (AB014044) and Poronia punctata (AF064052) than to three representative genera of Amphishaeriaceae: Pestalosphaeria hansenii (AF242846), Discostroma tricellular (AF346546) and Amphisphaeria sp.
- M. roseus While the molecular biology of M. roseus shows that this organism has the best fit into the group - Xylariaceae, it also demonstrates close 18Sr DNA relatedness to M. albus. However, because there is such relatedness at the limited r-DNA molecular level, it may be argued that the two fungi are identical. Nevertheless, other chemical characters in both M. albus and M. roseus were examined and discovered to be different. Thus, while both M. albus and M. roseus shared the biochemical ability of producing a musty smelling odor, which has been demonstrated to have powerful antibiotic properties, many of the volatiles produced by these two organisms were identical as measured by GC/MS.
- M. roseus On the other hand, both isolates of M. roseus made compounds not detected in M. albus volatiles, such as 2-butenoic acid, ethyl ester; 1,2,4, trimethyl benzene and 2,3 nonadiene. This result lends some chemical support to the assignment given in this report suggesting that M. albus is taxonomically distinct from M. roseus.
- M. roseus Other, more classical features of M. roseus (isolates" A3-5" and “A-10") were also examined and compared to M. albus. These isolates of M. roseus produced a slow growing, dense, lightly rose colored mycelium on all media tested. This contrasts to M. albus that produces a whitish mycelium on all comparable media tested (Worapong et al., 2001). No spores formed on any medium including ones containing the host plant material or carnation leaves. Hyphae varied in diameter (0.8-3.6 ⁇ m) and were often intertwined to make more complex structures and even hyphal coils. These hyphae were generally bigger than those of M. albus. The mycelia of M. roseus generally make more complex intertwined structures in culture than M. albus. In fact, the appearance of hyphal coils of fungi in culture is not common, in our experience, and yet these structures often appeared in M. roseus cultures.
- M. roseus the best storage condition was after drying on filter paper and placement at -70°C. Under these conditions the fungus remains viable for over 1.5 years. Also, this fungus could be stored at 4°C in sterile water but with less certainty of recovering a viable organism after 6 months. Also, storage in 15 % glycerol at -70°C effectively preserved the viability of the organism.
- Table 1 The effects of the volatile compounds of M. albus and an artificial mixture of M. albus compounds on a group of test microbes.
- the amount of each positively identified compound used in the artificial mixture was obtained by applying the electron ionization cross section (% ofthe total area) ofthe compound obtained in the GC/MS analysis.
- the artificial mixtures were subsequently tested by placing them in a pre-sterilized microcup (4x6 mm) located in the center of a test Petri plate containing PDA.
- Agar plugs containing freshly growing test microbes (or streaked microbes) were positioned about 2-3 cm from the center microcup. Then the plate was wrapped with 2 layers of parafilm and incubated for two or more days at 23°C. Measurements of linear mycelial growth were made from the edge ofthe inoculum agar plug to the edge ofthe mycelial colony. # Not measured in this experimental design.
- Table 2 Average number of broccoli seedlings per pot one week after planting (means ⁇ standard deviation) using vermiculite.
Abstract
Description
Claims
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT02741671T ATE445323T1 (en) | 2001-04-16 | 2002-04-11 | NEW ENDOPHYTIC MUSHROOMS AND THEIR USE |
MXPA03009468A MXPA03009468A (en) | 2001-04-16 | 2002-04-11 | Novel endophytic fungi and methods of use. |
EP02741671A EP1379126B9 (en) | 2001-04-16 | 2002-04-11 | Novel endophytic fungi and methods of use |
BRPI0208931A BRPI0208931B1 (en) | 2001-04-16 | 2002-04-11 | METHODS OF INHIBITING THE GROWTH OF A FRUIT, TREATMENT OR PROTECTION BODY, PLANT, SEED, GRAIN OR SOIL CIRCUITING PLANTS AGAINST INFESTATION A BODY CONSTRUCTION AND TREATMENT PROTECTION ORGANISM A VOLATILE COMPOSITION |
AU2002314747A AU2002314747B8 (en) | 2001-04-16 | 2002-04-11 | Novel endophytic fungi and methods of use |
NZ529086A NZ529086A (en) | 2001-04-16 | 2002-04-11 | Method for obtaining Muscodor fungi comprising screening the fungi with volatiles of Muscodor albus or Muscodor roseus under culturing conditions |
DE60234020T DE60234020D1 (en) | 2001-04-16 | 2002-04-11 | NEW ENDOPHYTIC MUSHROOMS AND ITS USE |
BR0208931-9A BR0208931A (en) | 2001-04-16 | 2002-04-11 | Method for identifying new muscodor fungi, composition, method of inhibiting the growth of an organism, treating or protecting fruits, plants, seeds, grains or soil surrounding plants against an infestation by an organism, treating animal waste or humans, and to obtain a volatile composition, and, fungus |
KR1020037013407A KR100878086B1 (en) | 2001-04-16 | 2002-04-11 | Novel endophytic fungi and methods of use |
JP2002580717A JP2004535170A (en) | 2001-04-16 | 2002-04-11 | New endogenous fungi and their uses |
CA2443295A CA2443295C (en) | 2001-04-16 | 2002-04-11 | Novel endophytic fungi and methods of use |
IL15843202A IL158432A0 (en) | 2001-04-16 | 2002-04-11 | Novel endophytic fungi and methods of use |
DK02741671.8T DK1379126T5 (en) | 2001-04-16 | 2002-04-11 | New endophytic fungi and methods of use |
IL158432A IL158432A (en) | 2001-04-16 | 2003-10-15 | Novel endophytic fungi and methods of use |
ZA2003/08905A ZA200308905B (en) | 2001-04-16 | 2003-11-14 | Novel endophytic fungi and methods of use |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28390201P | 2001-04-16 | 2001-04-16 | |
US60/283,902 | 2001-04-16 | ||
US36307202P | 2002-03-11 | 2002-03-11 | |
US60/363,072 | 2002-03-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002082898A1 true WO2002082898A1 (en) | 2002-10-24 |
Family
ID=26962301
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/011769 WO2002082898A1 (en) | 2001-04-16 | 2002-04-11 | Novel endophytic fungi and methods of use |
Country Status (20)
Country | Link |
---|---|
US (4) | US6911338B2 (en) |
EP (1) | EP1379126B9 (en) |
JP (2) | JP2004535170A (en) |
KR (2) | KR100951483B1 (en) |
AT (1) | ATE445323T1 (en) |
AU (1) | AU2002314747B8 (en) |
BR (2) | BRPI0208931B1 (en) |
CA (1) | CA2443295C (en) |
CR (1) | CR7111A (en) |
CY (1) | CY1109570T1 (en) |
DE (1) | DE60234020D1 (en) |
DK (1) | DK1379126T5 (en) |
ES (1) | ES2333585T3 (en) |
IL (2) | IL158432A0 (en) |
MX (1) | MXPA03009468A (en) |
NZ (1) | NZ529086A (en) |
PT (1) | PT1379126E (en) |
TW (1) | TWI338042B (en) |
WO (1) | WO2002082898A1 (en) |
ZA (1) | ZA200308905B (en) |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1610610A2 (en) * | 2003-04-04 | 2006-01-04 | Montana State University | The application of volatile antibiotics and non-volatile inhibitors from muscodor spp. to control harmful microbes in human and animal wastes |
EP1648383A2 (en) * | 2003-07-17 | 2006-04-26 | Gary A. Strobel | Compositions related to a novel endophytic fungi and methods of use |
WO2010090818A2 (en) * | 2009-02-04 | 2010-08-12 | The United States Of America, As Represented By The Secretary Of Agriculture | Attractant for indian meal moth larvae |
CN102177893A (en) * | 2009-09-30 | 2011-09-14 | 浙江大洋化工股份有限公司 | Bactericide |
WO2014124361A1 (en) | 2013-02-11 | 2014-08-14 | Bayer Cropscience Lp | Compositions comprising a streptomyces-based biological control agent and another biological control agent |
WO2015160618A1 (en) | 2014-04-16 | 2015-10-22 | Bayer Cropscience Lp | Compositions comprising ningnanmycin and a biological control agent |
WO2016044529A1 (en) | 2014-09-17 | 2016-03-24 | Bayer Cropscience Lp | Compositions comprising recombinant bacillus cells and another biological control agent |
US9364006B2 (en) | 2012-05-30 | 2016-06-14 | Bayer Cropscience Ag | Composition comprising a biological control agent and a fungicide |
US9380787B2 (en) | 2012-05-30 | 2016-07-05 | Bayer Cropscience Ag | Composition comprising a biological control agent and a fungicide selected from inhibitors of amino acid or protein biosynthesis, inhibitors of ATP production and inhibitors of the cell wall synthesis |
US9386773B2 (en) | 2012-05-30 | 2016-07-12 | Bayer Cropscience Ag | Compositions comprising a biological control agent and a fungicide from the group consisting of inhibitors of the respiratory chain at complex I or II |
US9398770B2 (en) | 2012-05-30 | 2016-07-26 | Bayer Cropscience Ag | Compositions comprising a biological control agent and an insecticide |
US9497972B2 (en) | 2012-05-30 | 2016-11-22 | Bayer Cropscience Ag | Compositions comprising a biological control agent and an insecticide |
US9585399B2 (en) | 2012-05-30 | 2017-03-07 | Bayer Cropscience Ag | Compositions comprising a biological control agent and an insecticide |
US9596860B2 (en) | 2012-05-30 | 2017-03-21 | Bayer Cropscience Ag | Composition comprising a biological control agent and a fungicide selected from inhibitors of the mitosis and cell division or compounds having a multi-site action |
US9700056B2 (en) | 2012-05-30 | 2017-07-11 | Bayer Cropscience Ag | Composition comprising a biological control agent and a fungicide selected from inhibitors of the ergosterol biosynthesis |
US9907312B2 (en) | 2012-05-30 | 2018-03-06 | Bayer Cropscience Ag | Compositions comprising a biological control agent and an insecticide |
EP3292764A2 (en) | 2012-05-30 | 2018-03-14 | Bayer CropScience Aktiengesellschaft | Composition comprising a biological control agent and a fungicide selected from inhibitors of the respiratory chain at complex iii |
EP3318128A2 (en) | 2012-05-30 | 2018-05-09 | Bayer CropScience Aktiengesellschaft | Composition comprising a biological control agent and a fungicide |
US10306889B2 (en) | 2012-05-30 | 2019-06-04 | Bayer Cropscience Ag | Compositions comprising a biological control agent and an insecticide |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ529086A (en) * | 2001-04-16 | 2005-07-29 | Gary A Strobel | Method for obtaining Muscodor fungi comprising screening the fungi with volatiles of Muscodor albus or Muscodor roseus under culturing conditions |
AU2003282926A1 (en) * | 2002-10-15 | 2004-05-04 | Montana State University | Methods and compositions relating to the production of insect repellents by a novel endophytic fungus |
US7858362B2 (en) * | 2004-05-27 | 2010-12-28 | Montana State Universtiy | Method of using endophytic fungi to decontaminate and decompose human and animal wastes |
US8455395B2 (en) * | 2006-10-24 | 2013-06-04 | Irving Licensing, Inc. | Endophyte enhanced seedlings with increased pest tolerance |
WO2010115156A2 (en) * | 2009-04-03 | 2010-10-07 | Synthetic Genomics, Inc. | Endophytic fungus and uses therefor |
MY158356A (en) * | 2009-04-03 | 2016-09-30 | Synthetic Genomics Inc | Compositions of volatile organic compounds and methods of use thereof |
JO3416B1 (en) | 2009-04-27 | 2019-10-20 | Jeneil Biosurfactant Co Llc | Antimicrobial compositions and related methods of use |
WO2010132509A2 (en) * | 2009-05-11 | 2010-11-18 | Agraquest, Inc. | Compounds derived from muscodor fungi |
US9090921B2 (en) | 2010-05-18 | 2015-07-28 | Gary A. Strobel | Method of producing volatile organic compounds from microorganisms |
US9624515B2 (en) | 2010-05-18 | 2017-04-18 | Gary A. Strobel | System and method of producing volatile organic compounds from fungi |
EP2571995A4 (en) * | 2010-05-18 | 2014-01-22 | Gary A Strobel | System and method of producing volatile organic compounds from fungi |
US9469836B2 (en) | 2011-01-28 | 2016-10-18 | J.D. Irving, Limited | Antifungal metabolites from fungal endophytes of Pinus strobus |
MY169833A (en) * | 2011-11-29 | 2019-05-16 | Malaysian Palm Oil Board | Compositions for controlling ganoderma disease in plants and method thereof by using endophytic fungus, hendersonia ganoef1 |
US20140086878A1 (en) * | 2012-09-25 | 2014-03-27 | Marrone Bio Innovations, Inc | Muscodor albus Strain Producing Volatile Organic Compounds and Methods of Use |
WO2014065589A1 (en) * | 2012-10-23 | 2014-05-01 | 한국화학연구원 | Lysinibacillus sphaericus tc1 strain, microbial preparation for controlling plant diseases comprising said strain, and plant disease control method using same |
WO2014165174A2 (en) * | 2013-03-12 | 2014-10-09 | Strobel Gary A | Microorganisms for producing volatile organic compounds and methods using same |
KR20200044153A (en) | 2013-03-15 | 2020-04-28 | 제네일 바이오서팩턴트 컴파니, 엘엘씨 | Antimicrobial compositions and related methods of use |
EP2865267A1 (en) | 2014-02-13 | 2015-04-29 | Bayer CropScience AG | Active compound combinations comprising phenylamidine compounds and biological control agents |
EP2865265A1 (en) | 2014-02-13 | 2015-04-29 | Bayer CropScience AG | Active compound combinations comprising phenylamidine compounds and biological control agents |
WO2016063963A1 (en) * | 2014-10-22 | 2016-04-28 | アース製薬株式会社 | Inhibitor for hatching of hematophagous pest eggs, pesticidal composition for hematophagous pests and pesticidal method for hematophagous pests |
CN104798820B (en) * | 2015-03-28 | 2018-02-09 | 浙江大学 | The preparation method of Fengyang aerogenesis removing mildew |
JP7408564B2 (en) | 2018-11-02 | 2024-01-05 | 日本農薬株式会社 | Pesticide composition and method of use thereof |
CN110295115B (en) * | 2019-05-27 | 2023-01-10 | 遵义医科大学 | Lichen endophytic fungus with broad-spectrum antibacterial activity |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4954497A (en) * | 1988-02-22 | 1990-09-04 | Takeda Chemical Industries, Ltd. | Acrylic acid morpholides and fungicidal compositions |
US5270340A (en) * | 1988-12-27 | 1993-12-14 | Bayer Aktiengesellschaft | Substituted 2-cyclohexen-1-yl-amine fungicidal and herbicidal agents |
US5612338A (en) * | 1993-01-29 | 1997-03-18 | Ciba-Geigy Corporation | Pyrazolyl acrylic acid derivatives, intermediates thereto, and in their use as microbicides |
US6310005B1 (en) * | 1998-09-16 | 2001-10-30 | Bayer Aktiengesellschaft | Isothiazole carboxylic acid amides |
Family Cites Families (101)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2281448A (en) * | 1941-09-17 | 1942-04-28 | Scully Signal Co | Device for partially obstructing pipes |
US3334629A (en) * | 1964-11-09 | 1967-08-08 | Bertram D Cohn | Occlusive device for inferior vena cava |
US3540431A (en) * | 1968-04-04 | 1970-11-17 | Kazi Mobin Uddin | Collapsible filter for fluid flowing in closed passageway |
US3868956A (en) * | 1972-06-05 | 1975-03-04 | Ralph J Alfidi | Vessel implantable appliance and method of implanting it |
US3952747A (en) * | 1974-03-28 | 1976-04-27 | Kimmell Jr Garman O | Filter and filter insertion instrument |
US3996938A (en) * | 1975-07-10 | 1976-12-14 | Clark Iii William T | Expanding mesh catheter |
BR8208063A (en) * | 1981-09-16 | 1984-01-10 | Hans Ivar Wallsten | DEVICE FOR APPLICATION IN BLOOD VESSELS OR OTHER DIFFICULT ACCESS PLACES AND THEIR USE |
US4425908A (en) * | 1981-10-22 | 1984-01-17 | Beth Israel Hospital | Blood clot filter |
SE445884B (en) * | 1982-04-30 | 1986-07-28 | Medinvent Sa | DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION |
US4494531A (en) * | 1982-12-06 | 1985-01-22 | Cook, Incorporated | Expandable blood clot filter |
US4503569A (en) * | 1983-03-03 | 1985-03-12 | Dotter Charles T | Transluminally placed expandable graft prosthesis |
US5067957A (en) * | 1983-10-14 | 1991-11-26 | Raychem Corporation | Method of inserting medical devices incorporating SIM alloy elements |
US5190546A (en) * | 1983-10-14 | 1993-03-02 | Raychem Corporation | Medical devices incorporating SIM alloy elements |
US4665906A (en) * | 1983-10-14 | 1987-05-19 | Raychem Corporation | Medical devices incorporating sim alloy elements |
US4572186A (en) * | 1983-12-07 | 1986-02-25 | Cordis Corporation | Vessel dilation |
US4576740A (en) | 1984-03-14 | 1986-03-18 | International Flavors & Fragrances Inc. | Tertiary pentamethylindanol derivatives and organoleptic uses thereof |
US4611594A (en) * | 1984-04-11 | 1986-09-16 | Northwestern University | Medical instrument for containment and removal of calculi |
US4727873A (en) * | 1984-04-17 | 1988-03-01 | Mobin Uddin Kazi | Embolus trap |
US5135531A (en) * | 1984-05-14 | 1992-08-04 | Surgical Systems & Instruments, Inc. | Guided atherectomy system |
US4957482A (en) * | 1988-12-19 | 1990-09-18 | Surgical Systems & Instruments, Inc. | Atherectomy device with a positive pump means |
US4842579B1 (en) * | 1984-05-14 | 1995-10-31 | Surgical Systems & Instr Inc | Atherectomy device |
DK151404C (en) * | 1984-05-23 | 1988-07-18 | Cook Europ Aps William | FULLY FILTER FOR IMPLANTATION IN A PATIENT'S BLOOD |
US4926858A (en) * | 1984-05-30 | 1990-05-22 | Devices For Vascular Intervention, Inc. | Atherectomy device for severe occlusions |
US4655772A (en) * | 1984-09-19 | 1987-04-07 | Liotta Holga E T De | Cardiac valvular prosthesis |
IT1186142B (en) * | 1984-12-05 | 1987-11-18 | Medinvent Sa | TRANSLUMINAL IMPLANTATION DEVICE |
US4807626A (en) * | 1985-02-14 | 1989-02-28 | Mcgirr Douglas B | Stone extractor and method |
US4699611A (en) * | 1985-04-19 | 1987-10-13 | C. R. Bard, Inc. | Biliary stent introducer |
US4690684A (en) * | 1985-07-12 | 1987-09-01 | C. R. Bard, Inc. | Meltable stent for anastomosis |
US4650466A (en) * | 1985-11-01 | 1987-03-17 | Angiobrade Partners | Angioplasty device |
US4733665C2 (en) * | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4681110A (en) * | 1985-12-02 | 1987-07-21 | Wiktor Dominik M | Catheter arrangement having a blood vessel liner, and method of using it |
US4649922A (en) * | 1986-01-23 | 1987-03-17 | Wiktor Donimik M | Catheter arrangement having a variable diameter tip and spring prosthesis |
US4669469A (en) * | 1986-02-28 | 1987-06-02 | Devices For Vascular Intervention | Single lumen atherectomy catheter device |
US4728319A (en) * | 1986-03-20 | 1988-03-01 | Helmut Masch | Intravascular catheter |
US4723549A (en) * | 1986-09-18 | 1988-02-09 | Wholey Mark H | Method and apparatus for dilating blood vessels |
SE455834B (en) * | 1986-10-31 | 1988-08-15 | Medinvent Sa | DEVICE FOR TRANSLUMINAL IMPLANTATION OF A PRINCIPLE RODFORMALLY RADIALLY EXPANDABLE PROSTHESIS |
US4800882A (en) * | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
US4817600A (en) * | 1987-05-22 | 1989-04-04 | Medi-Tech, Inc. | Implantable filter |
US4794928A (en) * | 1987-06-10 | 1989-01-03 | Kletschka Harold D | Angioplasty device and method of using the same |
US5210340A (en) * | 1987-07-30 | 1993-05-11 | Bayer Aktiengesellschaft | Preparation of polyfluorobutenes |
US4873978A (en) * | 1987-12-04 | 1989-10-17 | Robert Ginsburg | Device and method for emboli retrieval |
FR2624747A1 (en) * | 1987-12-18 | 1989-06-23 | Delsanti Gerard | REMOVABLE ENDO-ARTERIAL DEVICES FOR REPAIRING ARTERIAL WALL DECOLLEMENTS |
US4981602A (en) * | 1988-06-13 | 1991-01-01 | The Lubrizol Corporation | Lubricating oil compositions and concentrates |
US4830003A (en) * | 1988-06-17 | 1989-05-16 | Wolff Rodney G | Compressive stent and delivery system |
FR2632848A1 (en) * | 1988-06-21 | 1989-12-22 | Lefebvre Jean Marie | FILTER FOR MEDICAL USE |
US4832055A (en) * | 1988-07-08 | 1989-05-23 | Palestrant Aubrey M | Mechanically locking blood clot filter |
US4921484A (en) * | 1988-07-25 | 1990-05-01 | Cordis Corporation | Mesh balloon catheter device |
US5067489A (en) * | 1988-08-16 | 1991-11-26 | Flexmedics Corporation | Flexible guide with safety tip |
US4984581A (en) * | 1988-10-12 | 1991-01-15 | Flexmedics Corporation | Flexible guide having two-way shape memory alloy |
JPH02118178A (en) * | 1988-10-28 | 1990-05-02 | Mitsubishi Heavy Ind Ltd | Fibrous sheet with shape memory and provision of fibrous sheet product with shape memory nature |
US5011488A (en) * | 1988-12-07 | 1991-04-30 | Robert Ginsburg | Thrombus extraction system |
US4927426A (en) * | 1989-01-03 | 1990-05-22 | Dretler Stephen P | Catheter device |
US4856516A (en) * | 1989-01-09 | 1989-08-15 | Cordis Corporation | Endovascular stent apparatus and method |
FR2641692A1 (en) * | 1989-01-17 | 1990-07-20 | Nippon Zeon Co | Plug for closing an opening for a medical application, and device for the closure plug making use thereof |
US4935068A (en) * | 1989-01-23 | 1990-06-19 | Raychem Corporation | Method of treating a sample of an alloy |
US5152777A (en) * | 1989-01-25 | 1992-10-06 | Uresil Corporation | Device and method for providing protection from emboli and preventing occulsion of blood vessels |
US5728067A (en) * | 1989-01-30 | 1998-03-17 | C. R. Bard, Inc. | Rapidly exchangeable coronary catheter |
US4969891A (en) * | 1989-03-06 | 1990-11-13 | Gewertz Bruce L | Removable vascular filter |
EP0391384B1 (en) * | 1989-04-05 | 1994-08-31 | GIP Medizintechnik GmbH | Lithotriptor |
EP0408245B1 (en) * | 1989-07-13 | 1994-03-02 | American Medical Systems, Inc. | Stent placement instrument |
DE8910603U1 (en) * | 1989-09-06 | 1989-12-07 | Guenther, Rolf W., Prof. Dr. | |
US5059205A (en) * | 1989-09-07 | 1991-10-22 | Boston Scientific Corporation | Percutaneous anti-migration vena cava filter |
US5002560A (en) * | 1989-09-08 | 1991-03-26 | Advanced Cardiovascular Systems, Inc. | Expandable cage catheter with a rotatable guide |
US5034001A (en) * | 1989-09-08 | 1991-07-23 | Advanced Cardiovascular Systems, Inc. | Method of repairing a damaged blood vessel with an expandable cage catheter |
DE8910856U1 (en) * | 1989-09-12 | 1989-11-30 | Schneider (Europe) Ag, Zuerich, Ch | |
US5016808A (en) * | 1989-09-14 | 1991-05-21 | Cardiac Pacemakers, Inc. | Implantable tapered spiral endocardial lead for use in internal defibrillation |
US5100425A (en) * | 1989-09-14 | 1992-03-31 | Medintec R&D Limited Partnership | Expandable transluminal atherectomy catheter system and method for the treatment of arterial stenoses |
US5195955A (en) * | 1989-11-14 | 1993-03-23 | Don Michael T Anthony | Device for removal of embolic debris |
GB2238485B (en) * | 1989-11-28 | 1993-07-14 | Cook William Europ | A collapsible filter for introduction in a blood vessel of a patient |
US5041093A (en) * | 1990-01-31 | 1991-08-20 | Boston Scientific Corp. | Catheter with foraminous anchor |
FR2660189B1 (en) * | 1990-03-28 | 1992-07-31 | Lefebvre Jean Marie | DEVICE INTENDED TO BE IMPLANTED IN A VESSEL WITH SIDE LEGS WITH ANTAGONIST TEETH. |
US5221261A (en) * | 1990-04-12 | 1993-06-22 | Schneider (Usa) Inc. | Radially expandable fixation member |
IL94138A (en) * | 1990-04-19 | 1997-03-18 | Instent Inc | Device for the treatment of constricted fluid conducting ducts |
US5064435A (en) * | 1990-06-28 | 1991-11-12 | Schneider (Usa) Inc. | Self-expanding prosthesis having stable axial length |
CA2048307C (en) * | 1990-08-14 | 1998-08-18 | Rolf Gunther | Method and apparatus for filtering blood in a blood vessel of a patient |
US5160342A (en) * | 1990-08-16 | 1992-11-03 | Evi Corp. | Endovascular filter and method for use thereof |
US5108419A (en) * | 1990-08-16 | 1992-04-28 | Evi Corporation | Endovascular filter and method for use thereof |
US5100423A (en) * | 1990-08-21 | 1992-03-31 | Medical Engineering & Development Institute, Inc. | Ablation catheter |
US5053008A (en) * | 1990-11-21 | 1991-10-01 | Sandeep Bajaj | Intracardiac catheter |
US5415630A (en) * | 1991-07-17 | 1995-05-16 | Gory; Pierre | Method for removably implanting a blood filter in a vein of the human body |
US5192286A (en) * | 1991-07-26 | 1993-03-09 | Regents Of The University Of California | Method and device for retrieving materials from body lumens |
US5256146A (en) * | 1991-10-11 | 1993-10-26 | W. D. Ensminger | Vascular catheterization system with catheter anchoring feature |
CA2380683C (en) * | 1991-10-28 | 2006-08-08 | Advanced Cardiovascular Systems, Inc. | Expandable stents and method for making same |
FR2683449A1 (en) * | 1991-11-08 | 1993-05-14 | Cardon Alain | ENDOPROTHESIS FOR TRANSLUMINAL IMPLANTATION. |
CA2128338C (en) * | 1992-01-21 | 2004-10-12 | Gladwin S. Das | Septal defect closure device |
US5527338A (en) * | 1992-09-02 | 1996-06-18 | Board Of Regents, The University Of Texas System | Intravascular device |
US5382259A (en) * | 1992-10-26 | 1995-01-17 | Target Therapeutics, Inc. | Vasoocclusion coil with attached tubular woven or braided fibrous covering |
US5540707A (en) * | 1992-11-13 | 1996-07-30 | Scimed Life Systems, Inc. | Expandable intravascular occlusion material removal devices and methods of use |
FR2699809B1 (en) * | 1992-12-28 | 1995-02-17 | Celsa Lg | Device which can selectively constitute a temporary blood filter. |
US5354310A (en) * | 1993-03-22 | 1994-10-11 | Cordis Corporation | Expandable temporary graft |
US5514115A (en) * | 1993-07-07 | 1996-05-07 | Device For Vascular Intervention, Inc. | Flexible housing for intracorporeal use |
US5462529A (en) * | 1993-09-29 | 1995-10-31 | Technology Development Center | Adjustable treatment chamber catheter |
US5556389A (en) * | 1994-03-31 | 1996-09-17 | Liprie; Samuel F. | Method and apparatus for treating stenosis or other constriction in a bodily conduit |
US5690671A (en) * | 1994-12-13 | 1997-11-25 | Micro Interventional Systems, Inc. | Embolic elements and methods and apparatus for their delivery |
GB2304301B (en) * | 1995-08-16 | 2000-06-14 | Univ Southampton | Magnetic separation |
US5662671A (en) * | 1996-07-17 | 1997-09-02 | Embol-X, Inc. | Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries |
WO2002078451A1 (en) * | 2001-03-30 | 2002-10-10 | Premier Botanicals Ltd. | Pesticidal compositions from prunus |
NZ529086A (en) * | 2001-04-16 | 2005-07-29 | Gary A Strobel | Method for obtaining Muscodor fungi comprising screening the fungi with volatiles of Muscodor albus or Muscodor roseus under culturing conditions |
US7070985B2 (en) * | 2001-04-16 | 2006-07-04 | Montana State University | Application of volatile antibiotics and non-volatile inhibitors from Muscodor spp. to control harmful microbes in human and animal wastes |
US20040141955A1 (en) | 2001-04-16 | 2004-07-22 | Strobel Gary A. | Compositions related to a novel endophytic fungi and methods of use |
AU2003282926A1 (en) * | 2002-10-15 | 2004-05-04 | Montana State University | Methods and compositions relating to the production of insect repellents by a novel endophytic fungus |
-
2002
- 2002-04-11 NZ NZ529086A patent/NZ529086A/en not_active IP Right Cessation
- 2002-04-11 KR KR1020087027389A patent/KR100951483B1/en active IP Right Grant
- 2002-04-11 KR KR1020037013407A patent/KR100878086B1/en not_active IP Right Cessation
- 2002-04-11 BR BRPI0208931A patent/BRPI0208931B1/en unknown
- 2002-04-11 PT PT02741671T patent/PT1379126E/en unknown
- 2002-04-11 DE DE60234020T patent/DE60234020D1/en not_active Expired - Lifetime
- 2002-04-11 JP JP2002580717A patent/JP2004535170A/en active Pending
- 2002-04-11 AU AU2002314747A patent/AU2002314747B8/en not_active Ceased
- 2002-04-11 US US10/121,740 patent/US6911338B2/en not_active Expired - Lifetime
- 2002-04-11 MX MXPA03009468A patent/MXPA03009468A/en active IP Right Grant
- 2002-04-11 ES ES02741671T patent/ES2333585T3/en not_active Expired - Lifetime
- 2002-04-11 EP EP02741671A patent/EP1379126B9/en not_active Expired - Lifetime
- 2002-04-11 IL IL15843202A patent/IL158432A0/en active IP Right Grant
- 2002-04-11 AT AT02741671T patent/ATE445323T1/en active
- 2002-04-11 WO PCT/US2002/011769 patent/WO2002082898A1/en active Application Filing
- 2002-04-11 BR BR0208931-9A patent/BR0208931A/en active IP Right Grant
- 2002-04-11 CA CA2443295A patent/CA2443295C/en not_active Expired - Lifetime
- 2002-04-11 DK DK02741671.8T patent/DK1379126T5/en active
- 2002-04-15 TW TW091107629A patent/TWI338042B/en not_active IP Right Cessation
-
2003
- 2003-10-15 CR CR7111A patent/CR7111A/en unknown
- 2003-10-15 IL IL158432A patent/IL158432A/en unknown
- 2003-11-14 ZA ZA2003/08905A patent/ZA200308905B/en unknown
-
2005
- 2005-05-17 US US11/131,659 patent/US7754203B2/en active Active
-
2009
- 2009-12-04 JP JP2009276630A patent/JP2010077156A/en active Pending
- 2009-12-09 CY CY20091101289T patent/CY1109570T1/en unknown
-
2010
- 2010-05-25 US US12/786,434 patent/US8093024B2/en not_active Expired - Lifetime
-
2011
- 2011-12-02 US US13/310,567 patent/US20120114610A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4954497A (en) * | 1988-02-22 | 1990-09-04 | Takeda Chemical Industries, Ltd. | Acrylic acid morpholides and fungicidal compositions |
US5270340A (en) * | 1988-12-27 | 1993-12-14 | Bayer Aktiengesellschaft | Substituted 2-cyclohexen-1-yl-amine fungicidal and herbicidal agents |
US5612338A (en) * | 1993-01-29 | 1997-03-18 | Ciba-Geigy Corporation | Pyrazolyl acrylic acid derivatives, intermediates thereto, and in their use as microbicides |
US6310005B1 (en) * | 1998-09-16 | 2001-10-30 | Bayer Aktiengesellschaft | Isothiazole carboxylic acid amides |
Cited By (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1610610A2 (en) * | 2003-04-04 | 2006-01-04 | Montana State University | The application of volatile antibiotics and non-volatile inhibitors from muscodor spp. to control harmful microbes in human and animal wastes |
EP1610610A4 (en) * | 2003-04-04 | 2006-08-02 | Univ Montana State | The application of volatile antibiotics and non-volatile inhibitors from muscodor spp. to control harmful microbes in human and animal wastes |
EP1648383A2 (en) * | 2003-07-17 | 2006-04-26 | Gary A. Strobel | Compositions related to a novel endophytic fungi and methods of use |
JP2007524647A (en) * | 2003-07-17 | 2007-08-30 | ガリー エー. シュトローベル, | Compositions and methods of use for new endophytic bacteria |
EP1648383A4 (en) * | 2003-07-17 | 2010-07-28 | Gary A Strobel | Compositions related to a novel endophytic fungi and methods of use |
WO2010090818A2 (en) * | 2009-02-04 | 2010-08-12 | The United States Of America, As Represented By The Secretary Of Agriculture | Attractant for indian meal moth larvae |
WO2010090818A3 (en) * | 2009-02-04 | 2010-10-28 | The United States Of America, As Represented By The Secretary Of Agriculture | Attractant for indian meal moth larvae |
CN102177893A (en) * | 2009-09-30 | 2011-09-14 | 浙江大洋化工股份有限公司 | Bactericide |
EP3292764A2 (en) | 2012-05-30 | 2018-03-14 | Bayer CropScience Aktiengesellschaft | Composition comprising a biological control agent and a fungicide selected from inhibitors of the respiratory chain at complex iii |
US9700056B2 (en) | 2012-05-30 | 2017-07-11 | Bayer Cropscience Ag | Composition comprising a biological control agent and a fungicide selected from inhibitors of the ergosterol biosynthesis |
US10306889B2 (en) | 2012-05-30 | 2019-06-04 | Bayer Cropscience Ag | Compositions comprising a biological control agent and an insecticide |
EP3488700A1 (en) | 2012-05-30 | 2019-05-29 | Bayer CropScience Aktiengesellschaft | Composition comprising a biological control agent and a fungicide |
US9364006B2 (en) | 2012-05-30 | 2016-06-14 | Bayer Cropscience Ag | Composition comprising a biological control agent and a fungicide |
US9380787B2 (en) | 2012-05-30 | 2016-07-05 | Bayer Cropscience Ag | Composition comprising a biological control agent and a fungicide selected from inhibitors of amino acid or protein biosynthesis, inhibitors of ATP production and inhibitors of the cell wall synthesis |
US9386773B2 (en) | 2012-05-30 | 2016-07-12 | Bayer Cropscience Ag | Compositions comprising a biological control agent and a fungicide from the group consisting of inhibitors of the respiratory chain at complex I or II |
US9398770B2 (en) | 2012-05-30 | 2016-07-26 | Bayer Cropscience Ag | Compositions comprising a biological control agent and an insecticide |
US9497972B2 (en) | 2012-05-30 | 2016-11-22 | Bayer Cropscience Ag | Compositions comprising a biological control agent and an insecticide |
US9585399B2 (en) | 2012-05-30 | 2017-03-07 | Bayer Cropscience Ag | Compositions comprising a biological control agent and an insecticide |
US9596860B2 (en) | 2012-05-30 | 2017-03-21 | Bayer Cropscience Ag | Composition comprising a biological control agent and a fungicide selected from inhibitors of the mitosis and cell division or compounds having a multi-site action |
EP3363289A2 (en) | 2012-05-30 | 2018-08-22 | Bayer CropScience Aktiengesellschaft | Compositions comprising a biological control agent and an insecticide |
EP3205210A1 (en) | 2012-05-30 | 2017-08-16 | Bayer CropScience Aktiengesellschaft | Composition comprising a biological control agent and a fungicide selected from inhibitors of the succinate dehydrogenase |
EP3243387A2 (en) | 2012-05-30 | 2017-11-15 | Bayer CropScience Aktiengesellschaft | Compositions comprising a biological control agent and an insecticide |
EP3281526A1 (en) | 2012-05-30 | 2018-02-14 | Bayer CropScience Aktiengesellschaft | Composition comprising a biological control agent and a fungicide |
US9907312B2 (en) | 2012-05-30 | 2018-03-06 | Bayer Cropscience Ag | Compositions comprising a biological control agent and an insecticide |
EP3360418A1 (en) | 2012-05-30 | 2018-08-15 | Bayer CropScience Aktiengesellschaft | Composition comprising a biological control agent and a fungicide |
EP3300603A2 (en) | 2012-05-30 | 2018-04-04 | Bayer CropScience Aktiengesellschaft | Composition comprising a biological control agent and a fungicide |
EP3318128A2 (en) | 2012-05-30 | 2018-05-09 | Bayer CropScience Aktiengesellschaft | Composition comprising a biological control agent and a fungicide |
US9968097B2 (en) | 2012-05-30 | 2018-05-15 | Bayer Cropscience Ag | Composition comprising a biological control agent and a fungicide selected from inhibitors of the lipid membrane synthesis, the melanine biosynthesis, the nucleic acid synthesis or the signal transduction |
WO2014124361A1 (en) | 2013-02-11 | 2014-08-14 | Bayer Cropscience Lp | Compositions comprising a streptomyces-based biological control agent and another biological control agent |
WO2014124375A1 (en) | 2013-02-11 | 2014-08-14 | Bayer Cropscience Lp | Compositions comprising gougerotin and a biological control agent |
WO2015160618A1 (en) | 2014-04-16 | 2015-10-22 | Bayer Cropscience Lp | Compositions comprising ningnanmycin and a biological control agent |
WO2016044529A1 (en) | 2014-09-17 | 2016-03-24 | Bayer Cropscience Lp | Compositions comprising recombinant bacillus cells and another biological control agent |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8093024B2 (en) | Endophytic fungi and methods of use | |
AU2002314747A1 (en) | Novel endophytic fungi and methods of use | |
Chaudhary et al. | Bioefficacy of novel cyanobacteria-amended formulations in suppressing damping off disease in tomato seedlings | |
Strobel et al. | Muscodor albus E-6, an endophyte of Guazuma ulmifolia making volatile antibiotics: isolation, characterization and experimental establishment in the host plant | |
Mu et al. | Biocontrol potential of vermicompost through antifungal volatiles produced by indigenous bacteria | |
US20040141955A1 (en) | Compositions related to a novel endophytic fungi and methods of use | |
US7858362B2 (en) | Method of using endophytic fungi to decontaminate and decompose human and animal wastes | |
Youssef | Evaluation of composted chicken manure in biocontrolling Fusarium wilt on tomato | |
Keloth et al. | Efficacy of Organic Substrates for Management of Soil-Borne Plant Pathogens | |
Yasin et al. | ANTAGONISTIC ACTIVITY AND PLANT GROWTH PROMOTING RHIZOBACTERIA ISOLATED FROM FOREST PLANT RHIZOSPHERE AGAINST FUSARIUM SOLANI ON THUJA SEEDLINGS | |
Rhoda | The efficacy of selected indigenous entomopathogenic fungal strains against the grapevine mealybug, Planococcus ficus | |
Bradley | Supression of Fusarium root and stem rot of greenhouse cucumber using composts containing fluorescent pseudomonads | |
Yogev | Suppression mechanism of Fusarium Wilt of melon caused by Fusarium oxysporum f. sp. melonis by compost | |
Saido | Suppression of Rhizoctonia Damping-off of Chickpea Using Manure Extracts and Their Associated Fungi | |
Yang | Investigations into Peach Replant Disease and Nematophagous Fungi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2443295 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020037013407 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002741671 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 158432 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002580717 Country of ref document: JP Ref document number: PA/a/2003/009468 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002314747 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 529086 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003/08905 Country of ref document: ZA Ref document number: 200308905 Country of ref document: ZA |
|
WWP | Wipo information: published in national office |
Ref document number: 2002741671 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 529086 Country of ref document: NZ |
|
WWP | Wipo information: published in national office |
Ref document number: 529086 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020087027389 Country of ref document: KR |